- Home
- DSP vs FENC Comparison
DSP vs FENC Comparison
Compare DSP & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- FENC
- Stock Information
- Founded
- DSP 1999
- FENC 1996
- Country
- DSP United States
- FENC United States
- Employees
- DSP N/A
- FENC N/A
- Industry
- DSP EDP Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSP Technology
- FENC Health Care
- Exchange
- DSP Nasdaq
- FENC Nasdaq
- Market Cap
- DSP 220.3M
- FENC 222.9M
- IPO Year
- DSP 2021
- FENC 2001
- Fundamental
- Price
- DSP $13.78
- FENC $8.40
- Analyst Decision
- DSP Strong Buy
- FENC Strong Buy
- Analyst Count
- DSP 8
- FENC 2
- Target Price
- DSP $21.75
- FENC $13.00
- AVG Volume (30 Days)
- DSP 238.8K
- FENC 80.0K
- Earning Date
- DSP 08-11-2025
- FENC 08-12-2025
- Dividend Yield
- DSP N/A
- FENC N/A
- EPS Growth
- DSP N/A
- FENC N/A
- EPS
- DSP 0.13
- FENC N/A
- Revenue
- DSP $306,484,000.00
- FENC $30,912,000.00
- Revenue This Year
- DSP $18.36
- FENC $0.85
- Revenue Next Year
- DSP $15.95
- FENC $55.16
- P/E Ratio
- DSP $106.28
- FENC N/A
- Revenue Growth
- DSP 30.64
- FENC N/A
- 52 Week Low
- DSP $8.70
- FENC $3.96
- 52 Week High
- DSP $26.33
- FENC $8.88
- Technical
- Relative Strength Index (RSI)
- DSP 48.96
- FENC 63.33
- Support Level
- DSP $12.79
- FENC $7.94
- Resistance Level
- DSP $13.58
- FENC $8.51
- Average True Range (ATR)
- DSP 0.57
- FENC 0.41
- MACD
- DSP 0.06
- FENC -0.01
- Stochastic Oscillator
- DSP 76.06
- FENC 89.80
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.